2026-07-29T23:17:44.065Z / 路透社
作者：伊斯梅尔·沙基尔
2026年7月29日 世界标准时间23:17 更新于4分钟前
REUTERS/Dado Ruvic/Illustration/File Photo 购买授权许可，打开新标签页
7月29日（路透社）——特朗普政府周三表示，将立即拨付国会划拨的6亿美元资金，用于为全球最贫困国家提供疫苗。此前，美国卫生部长小罗伯特·F·肯尼迪提出了毫无依据的安全担忧，导致华盛顿扣留了这笔款项。
美国国务卿马可·卢比奥曾于6月表示，是时候重新参与总部位于日内瓦的全球疫苗联盟Gavi了。该联盟帮助全球最贫困国家购买疫苗，以保护儿童免受麻疹、白喉等疾病的威胁，卢比奥当时提及了国会的担忧以及“我们在全球卫生领域的目标”。
路透社每日简报通讯为您提供开启一天所需的全部新闻。在此注册。
广告 · 滚动继续
举报广告！
上个月，Gavi首席执行官萨尼亚·尼什塔尔曾表示，Gavi正在逐步淘汰含有汞基防腐剂的疫苗，而肯尼迪此前就这类疫苗提出了担忧。
美国国务院周三在一份声明中表示，在Gavi承诺“致力于逐步淘汰含汞疫苗，并扩大获取新型无汞替代品的渠道”后，美国做出了拨付资金的决定。
Gavi的代表并未立即回应周三晚些时候在日内瓦发出的置评请求。
包括肯尼迪创立的组织在内的反疫苗团体，数十年来一直声称疫苗中使用的汞基防腐剂硫柳汞与自闭症及其他神经发育障碍有关，尽管多项研究并未发现相关安全问题。
广告 · 滚动继续
长期以来的疫苗怀疑论者肯尼迪曾在2025年6月表示，美国将不再提供任何资助——每年约3亿美元——因为Gavi无视安全问题。他并未提供证据支持这一说法。
美国此前约占Gavi资金的13%，该组织已采取一系列削减成本的措施，以试图解决资金缺口，而其他高收入国家的削减进一步加剧了这一缺口。
周三，国务院表示，美国有望重新获得Gavi董事会席位，并将根据改革的“已证明的绩效、问责制和实施情况”，评估美国未来对该组织的任何支持。
由伊斯梅尔·沙基尔和卡尼什卡·辛格报道；贾斯珀·沃德、唐娜·布赖森和林肯·菲斯特编辑。
我们的准则：汤森路透信托原则。
Trump administration unfreezes $600 million for Gavi for global vaccine effort
2026-07-29T23:17:44.065Z / Reuters
By Ismail Shakil
July 29, 2026 11:17 PM UTC Updated 4 mins ago
The Vaccine Alliance (GAVI) logo and U.S. flag are seen in this illustration taken April 23, 2025. REUTERS/Dado Ruvic/Illustration/File Photo Purchase Licensing Rights, opens new tab
July 29 (Reuters) – The Trump administration said on Wednesday it will immediately release $600 million in congressionally appropriated funds for vaccines for the world’s poorest countries after Washington withheld the money over unsubstantiated safety concerns raised by U.S. Health Secretary Robert F. Kennedy Jr.
U.S. Secretary of State Marco Rubio had said in June that it was time to re-engage with the Geneva-based global alliance Gavi, which helps the world’s poorest countries buy vaccines to protect children from diseases such as measles and diphtheria, citing both congressional concerns and “our goals on global health.”
The Reuters Daily Briefing newsletter provides all the news you need to start your day. Sign up here.
Advertisement · Scroll to continue
Report Ad!
The previous month, Gavi’s chief executive Sania Nishtar had said Gavi was moving away from vaccines that included a mercury-based preservative about which Kennedy had raised concerns.
The U.S. State Department said in a statement on Wednesday the decision to release funds was taken after Gavi committed “to work towards transitioning mercury-containing vaccines and expanding access to newer, mercury-free alternatives.”
Representatives for Gavi did not immediately respond to a request for comment sent late Wednesday night in Geneva.
Anti-vaccine groups, including one founded by Kennedy, have for decades claimed that thimerosal, a mercury-based preservative used in vaccines, is linked to autism and other neurodevelopmental disorders, despite many studies showing no related safety issues.
Advertisement · Scroll to continue
Kennedy, a longtime vaccine skeptic, said in June 2025 the U.S. would no longer provide any funding – representing around $300 million a year – because Gavi ignored safety. He did not provide evidence to support his claim.
The U.S. previously contributed around 13% of Gavi’s funding, and the organization has embarked on a series of cost-cutting measures to try to address the shortfall, which has been exacerbated by cuts from other high-income nations.
On Wednesday, the State Department said the U.S. expects to resume its place on the Gavi board and that it will evaluate any future U.S. support to the group based on “demonstrated performance, accountability, and implementation” of reforms.”
Reporting by Ismail Shakil and Kanishka Singh; Editing by Jasper Ward, Donna Bryson and Lincoln Feast.
Our Standards: The Thomson Reuters Trust Principles.
发表回复